All Stories

  1. Novel therapy designed to limit brain damage and improve cognitive abilities in Alzheimer’s disease
  2. Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”
  3. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications
  4. Molecular and cellular biology of PCSK9: impact on glucose homeostasis
  5. Editorial for “New Cluster Analysis Method for Quantitative DCE‐MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model”
  6. Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents
  7. Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement
  8. Comparative study of the visual system of two psammophilic lizards (Scincus scincus & Eumeces schneideri)
  9. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes
  10. Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models
  11. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa
  12. Molecular imaging by MRI of brain amyloid burden for Alzheimer's disease diagnosis
  13. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1
  14. Synthesis, Characterization, and Toxicity Evaluation of Dextran-Coated Iron Oxide Nanoparticles
  15. Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium
  16. Chemical andin vitrocharacterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging
  17. Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC
  18. Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells
  19. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imag
  20. Hard corona composition and cellular toxicities of the graphene sheets
  21. Significance of cell “observer” and protein source in nanobiosciences
  22. Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions
  23. Phage Display Screening for Tumor Necrosis Factor-α-Binding Peptides: Detection of Inflammation in a Mouse Model of Hepatitis
  24. A Tripodal Ruthenium–Gadolinium Metallostar as a Potential αvβ3Integrin Specific Bimodal Imaging Contrast Agent
  25. Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide Derivatives
  26. Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging
  27. Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”
  28. Cell “vision”: complementary factor of protein corona in nanotoxicology
  29. A Modular Approach towards the Synthesis of Target-Specific MRI Contrast Agents
  30. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library
  31. Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-Tumour Agents
  32. Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease
  33. Ultrasmall particle of iron oxide—RGD peptidomimetic conjugate: synthesis and characterisation
  34. In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties
  35. Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents
  36. Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques
  37. How to quantify iron in an aqueous or biological matrix: a technical note
  38. Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe
  39. Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA†
  40. From Phage Display to Magnetophage, a New Tool for Magnetic Resonance Molecular Imaging
  41. A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
  42. Pharmacokinetic andin vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity
  43. C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI
  44. Synthesis, Characterization, and Pharmacokinetic Evaluation of a Potential MRI Contrast Agent Containing Two Paramagnetic Centers with Albumin Binding Affinity
  45. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent
  46. Ferritin-induced relaxation in tissues: An in vitro study
  47. Spin–spin relaxation times in myocardial hypertrophy induced by endocrine agents in rat